PQ Insights

Overview This report summarises key Parliamentary Questions (PQs) submitted during the June – July 2025 period. The inquiries cover a diverse range of policy areas, with significant focus on public health and security, including women’s health and gain-of-function research; agriculture and environmental policy, with questions on the future of the CAP and water management; foreign […]

This week’s EU health policy developments range from workforce pressures and medicine shortages to rare disease research, PFAS monitoring, and crisis preparedness. Key issues include newborn screening disparities, mental health, and data ethics in digital health and AI regulation.

This week’s EU health and governance developments range from healthcare access and ME/CFS research to glyphosate safety, burnout prevention, and humanitarian issues in Gaza. The Commission’s replies highlight growing focus on patient rights, vaccine safety, disability inclusion, and transparency in EU governance.

This week’s EU health and regulatory developments range from youth vaping and tobacco-control reforms to food safety, cardiovascular health, and healthcare cybersecurity. The Commission also addressed glyphosate safety, NGO funding oversight, and industrial cases like the Tesla Gigafactory, underscoring a strong enforcement and transparency agenda.

This week’s EU health and policy developments range from vaccine liability, disease preparedness, and women’s health to food additives, medical device reform, and healthcare funding. The Commission reaffirmed its commitments on vaccine safety, climate resilience, data protection, and equitable access to medicines and care across Member States.